Table 2. Average concentrations (n = 3) of antibiotics in vicinity of drug formulation facilities (ng L−1).
| Antibiotics | P1a | P1b | P2 | P3 | P4 |
| SDZ | 19(80) | 140(90) | <LOQ | 10(110) | 290(30) |
| LIN | 22(30) | 270(40) | 530(120) | 330(70) | 4100(60) |
| TRI | 18(50) | 570(100) | 73(90) | 1000(110) | 28000(100) |
| ENX | 3.5(140) | 0.4(110) | 4.9(140) | <LOQ | <LOQ |
| OXY | <LOQ | 160(50) | 1.2(120) | 76(50) | 27000(90) |
| OFL | 2.0(10) | 90(80) | 6.4(130) | 120(60) | 7300(20) |
| LEV | 1.8(10) | 68(70) | 7.0(130) | 130(70) | 8000(10) |
| NOR | <LOQ | <LOQ | 4.5(40) | 45(60) | 140(20) |
| PEF | <LOQ | 1.5(100) | <LOQ | 8.3(60) | 82(20) |
| CIP | 1.04(20) | 31(90) | 2.0(90) | 91(70) | 6200(30) |
| CEF | <LOQ | <LOQ | <LOQ | 59(140) | 52(140) |
| LOM | <LOQ | 0.8(100) | 1.0(110) | 3.4(40) | 8.7(30) |
| TET | <LOQ | 50(40) | 11(100) | 28(70) | 380(70) |
| ENR | <LOQ | 7.9(110) | 0.7(60) | 3.4(60) | 5.0(40) |
| AZI | 2.0(30) | 35(100) | 2.2(80) | 21(70) | 8.9(70) |
| CLI | <LOQ | 1.0(20) | 0.6(40) | 2.2(110) | 0.2(70) |
| SULM | 70(40) | 520(50) | 160(80) | 4700(100) | 49000(20) |
| DOX | 3.0(10) | 230(30) | 5.5(100) | 52(100) | 370(20) |
| ERY | 6.3(50) | 290(100) | 34(60) | 62(40) | 1100(10) |
| NAL | <LOQ | 49(90) | 16(60) | 44(40) | 220(10) |
| CLA | 6.2(20) | 190(60) | 60(50) | 360(30) | 19(50) |
| ROX | 1.4(20) | 240(60) | 37(50) | 270(70) | 3.0(20) |